Clinical Trial Update: Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Beads versus Doxorubicin-eluting Beads for arterial embolization in hepatocellular carcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Beads
• Doxorubicin-eluting beads (doxorubicin-eluting beads)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Hepatocellular Carcinoma, Liver Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-08-18